GENOVA, Inc. (TYO:9341)
Japan · Delayed Price · Currency is JPY | Market Cap | 10.75B -10.4% |
| Revenue (ttm) | 12.77B +36.9% |
| Net Income | 623.48M -33.0% |
| EPS | 35.61 -32.1% |
| Shares Out | 17.34M |
| PE Ratio | 17.41 |
| Forward PE | n/a |
| Dividend | 30.00 (4.78%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 51,400 |
| Open | 621.00 |
| Previous Close | 620.00 |
| Day's Range | 618.00 - 629.00 |
| 52-Week Range | 541.00 - 693.00 |
| Beta | -0.12 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |
About GENOVA
GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles; and online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital. It also provides Smart Clinic, such as NOMOCa-Stand, a smart and simple automatic payment and reception machine; NOMOCa-Regi, a self-pay machine dedicated to the c... [Read more]
Financial Performance
In fiscal year 2026, GENOVA's revenue was 11.57 billion, an increase of 15.58% compared to the previous year's 10.01 billion. Earnings were 275.00 million, a decrease of -80.54%.
Financial StatementsNews
Check Your Pantry ASAP for This Recalled Canned Tuna Brand
Tri-Union Seafoods announced a recall of canned tuna sold under the Trader Joe's, Genova, Van Camp's and H-E-B brand names due to quality and safety concerns.